At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ATR AptarGroup
Market Closed 02-27 16:00:00 EST
143.71
+1.92
+1.35%
盘后143.71
+0.000.00%
16:19 EST
High144.01Low141.00Vol344.66K
Open141.53D1 Closing141.79Amplitude2.12%
Mkt Cap9.25BTradable Cap9.25BTotal Shares64.38M
T/O49.40MT/O Rate0.54%Tradable Shares64.38M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

AptarGroup: Solid Strategic Position and Structural Growth Offset by Near-Term Earnings Headwinds, Warranting a Hold Rating
TIPRANKS  ·  02-26 10:15
AptarGroup: Solid Strategic Position and Structural Growth Offset by Near-Term Earnings Headwinds, Warranting a Hold Rating
AptarGroup Inc. Publishes Investor Presentation on Drug and Consumer Product Dosing, Dispensing and Protection Technologies
Reuters  ·  02-25
AptarGroup Inc. Publishes Investor Presentation on Drug and Consumer Product Dosing, Dispensing and Protection Technologies
AptarGroup Segment President Gael Touya Disposes of Common Shares
Reuters  ·  02-19
AptarGroup Segment President Gael Touya Disposes of Common Shares
AptarGroup to Present at Bank of America Securities Global Agriculture and Materials Conference
Reuters  ·  02-19
AptarGroup to Present at Bank of America Securities Global Agriculture and Materials Conference
Top AptarGroup Executive Makes Eye-Catching Move With Company Stock
TIPRANKS  ·  02-12
Top AptarGroup Executive Makes Eye-Catching Move With Company Stock
AptarGroup Segment President Marc Prieur Reports Sale of Common Shares
Reuters  ·  02-12
AptarGroup Segment President Marc Prieur Reports Sale of Common Shares
AptarGroup Earnings Call Balances Growth With Margin Strain
TIPRANKS  ·  02-10
AptarGroup Earnings Call Balances Growth With Margin Strain
Balanced View on AptarGroup: Solid Underlying Pharma Performance Offset by Near-Term Headwinds and Underwhelming Beauty & Closures, Justifying a Hold Rating
TIPRANKS  ·  02-09
Balanced View on AptarGroup: Solid Underlying Pharma Performance Offset by Near-Term Headwinds and Underwhelming Beauty & Closures, Justifying a Hold Rating
U.S. RESEARCH ROUNDUP-Align Technology, Biogen, Citigroup
Reuters  ·  02-09
U.S. RESEARCH ROUNDUP-Align Technology, Biogen, Citigroup
Aptargroup Inc : Baird Raises Target Price to $156 From $145
THOMSON REUTERS  ·  02-09
Aptargroup Inc : Baird Raises Target Price to $156 From $145
AptarGroup Gains After 4Q Results, Buyback Plan
Dow Jones  ·  02-07
AptarGroup Gains After 4Q Results, Buyback Plan
AptarGroup Up Over 7%, on Pace for Largest Percent Increase Since April -- Data Talk
Dow Jones  ·  02-07
AptarGroup Up Over 7%, on Pace for Largest Percent Increase Since April -- Data Talk
William Blair Releases a Hold Rating on AptarGroup (ATR)
TIPRANKS  ·  02-06
William Blair Releases a Hold Rating on AptarGroup (ATR)
AptarGroup sees Q1 adjusted EPS $1.13-$1.21, consensus $1.23
TIPRANKS  ·  02-06
AptarGroup sees Q1 adjusted EPS $1.13-$1.21, consensus $1.23
Aptar beats Q4 revenue, profit estimates; announces $600 mln buyback
Reuters  ·  02-06
Aptar beats Q4 revenue, profit estimates; announces $600 mln buyback
AptarGroup reports Q4 adjusted EPS $1.25, consensus $1.23
TIPRANKS  ·  02-06
AptarGroup reports Q4 adjusted EPS $1.25, consensus $1.23
AptarGroup Q4 Adj. EPS $1.25 Beats $1.23 Estimate, Sales $962.736M Beat $882.208M Estimate
Benzinga  ·  02-06
AptarGroup Q4 Adj. EPS $1.25 Beats $1.23 Estimate, Sales $962.736M Beat $882.208M Estimate
AptarGroup meldet für das erste Quartal einen den Aktionären zurechenbaren Nettogewinn von 78,80 Mio. USD und ein bereinigtes Ergebnis je Aktie von 1,17 USD
Reuters  ·  02-06
AptarGroup meldet für das erste Quartal einen den Aktionären zurechenbaren Nettogewinn von 78,80 Mio. USD und ein bereinigtes Ergebnis je Aktie von 1,17 USD
BRIEF-Aptar Q4 Adjusted EPS USD 1.25 Vs. IBES Estimate USD 1.23
Reuters  ·  02-06
BRIEF-Aptar Q4 Adjusted EPS USD 1.25 Vs. IBES Estimate USD 1.23
Aptargroup: Expects Adjusted Earnings per Share for the First Quarter of 2026 to Be in the Range of $1.13 to $1.21
THOMSON REUTERS  ·  02-06
Aptargroup: Expects Adjusted Earnings per Share for the First Quarter of 2026 to Be in the Range of $1.13 to $1.21

Introduction

Company Name.
AptarGroup
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Issue price:
--